Hunter Associates Investment Management LLC Buys 400 Shares of Colgate-Palmolive (NYSE:CL)

Hunter Associates Investment Management LLC boosted its position in Colgate-Palmolive (NYSE:CLFree Report) by 4.2% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 9,994 shares of the company’s stock after purchasing an additional 400 shares during the period. Hunter Associates Investment Management LLC’s holdings in Colgate-Palmolive were worth $711,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Gladstone Institutional Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock worth $476,000 after buying an additional 133 shares in the last quarter. Waldron Private Wealth LLC lifted its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after buying an additional 140 shares in the last quarter. Blue Fin Capital Inc. lifted its holdings in shares of Colgate-Palmolive by 1.1% in the second quarter. Blue Fin Capital Inc. now owns 12,549 shares of the company’s stock worth $967,000 after buying an additional 141 shares in the last quarter. Gratus Capital LLC lifted its holdings in shares of Colgate-Palmolive by 1.4% in the third quarter. Gratus Capital LLC now owns 10,048 shares of the company’s stock worth $714,000 after buying an additional 141 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Colgate-Palmolive by 48.2% in the second quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after buying an additional 145 shares in the last quarter. 78.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Bank of America raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 target price on the stock in a report on Friday, December 15th. Royal Bank of Canada upped their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company a “sector perform” rating in a research note on Monday, October 30th. Jefferies Financial Group assumed coverage on shares of Colgate-Palmolive in a research note on Monday, November 13th. They set a “buy” rating and a $87.00 price target on the stock. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, October 30th. Finally, Morgan Stanley upped their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Three analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $86.93.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.9 %

NYSE:CL opened at $83.46 on Monday. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $86.14. The company has a 50-day moving average of $80.38 and a 200 day moving average of $76.28. The firm has a market cap of $68.72 billion, a PE ratio of 30.02, a price-to-earnings-growth ratio of 3.66 and a beta of 0.42. The company has a debt-to-equity ratio of 21.40, a current ratio of 0.41 and a quick ratio of 0.26.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. During the same period in the prior year, the firm earned $0.77 earnings per share. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. As a group, research analysts anticipate that Colgate-Palmolive will post 3.48 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Monday, January 22nd will be given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Friday, January 19th. Colgate-Palmolive’s payout ratio is 69.06%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $77.83, for a total transaction of $1,167,450.00. Following the completion of the sale, the insider now directly owns 12,371 shares of the company’s stock, valued at $962,834.93. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $77.83, for a total transaction of $1,167,450.00. Following the completion of the sale, the insider now directly owns 12,371 shares of the company’s stock, valued at $962,834.93. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jennifer Daniels sold 3,800 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $79.01, for a total transaction of $300,238.00. Following the sale, the insider now directly owns 58,193 shares of the company’s stock, valued at $4,597,828.93. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 92,123 shares of company stock valued at $7,635,941. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.